Mirtazapine iMpurity
|
米氮平杂质
|
|
Montelukast iMpurity
|
孟鲁司特杂质
|
|
Mycophenolate IMpurity
|
霉酚酸杂质
|
|
|
阿夫唑嗪杂质
|
|
|
氨苄青霉素杂质
|
|
Atorvastatin Calcium Impurity VI Degradation Product
|
氧氟沙星光降解杂质
|
151377-74-1
|
|
奥沙利铂杂质
|
|
|
醋丁洛尔杂质
|
|
|
地尔硫卓杂质
|
|
|
多奈哌齐杂质
|
|
|
恩格列净杂质
|
|
|
恩他卡朋杂质
|
|
|
格列美脲杂质
|
|
|
环丙沙星杂质
|
|
|
甲氨蝶呤杂质
|
|
|
雷米普利杂质
|
|
|
洛伐他汀杂质
|
|
|
美洛昔康杂质
|
|
|
尼扎替丁杂质
|
|
|
帕潘立酮杂质
|
|
|
潘生丁杂质
|
|
|
培哚普利杂质
|
|
|
群多普利杂质
|
|
|
舒马曲坦杂质
|
|
|
双醋瑞因杂质
|
|
|
双氯芬酸杂质
|
|
|
佐米曲普坦杂质
|
|
|
唑吡坦杂质
|
|
Nebivolol O-Beta-D-Glucuronide
|
奈必洛尔杂质
|
|
nifedipine iMpurity
|
硝苯地平杂质
|
|
NiMesulide EP IMpurity
|
尼美舒利杂质
|
|
O-Isobutyryl (R)-Fesoterodine
|
弗斯特罗定杂质
|
1208313-13-6
|
OMEPRAZOLE IMPURITY DOMEPRAZOLE SULPHONE EP STANDARD
|
奥美拉唑杂质
|
|
OMEPRAZOLE IMPURITY DOMEPRAZOLE SULPHONE EP STANDARD
|
兰索拉唑杂质
|
1083100-27-9
|
Ondansetron IMpurity
|
恩丹西酮杂质
|
|
OseltaMivir iMpurity E
|
奥司他韦杂质
|
|
Paroxetine IMpurity
|
帕罗西汀杂质
|
|
Pioglitazone BroMo IMpurity
|
吡格列酮杂质
|
|
PiroxicaM IMpurity ( N-(2-Pyridinyl)oxaMic Acid )
|
吡罗昔康杂质
|
|
Pitavastatin IMpurity 4 (PP-4)
|
匹伐他汀杂质
|
|
Pravastatin iMpurity (6a-OH-iso-coMpactin OH acid)
|
普伐他汀杂质
|
|
Pregabalin IMpurity
|
普瑞巴林杂质
|
|
Quetiapine IMpurity [2-(2-Piperazin-1-yl)ethoxy)ethanol]
|
喹硫平杂质
|
|
Quinapril IMpuriy
|
喹那普利杂质
|
|
Rabeprazole iMpurity (Chloro interMediate
|
雷贝拉唑
|
117976-89-3
|
Raloxifene EP IMpurity
|
雷洛昔芬杂质
|
|
REPAGLINIDE RELATED COMPOUND C (25 MG) ((S)-2-ETHOXY-4-[2-[[2-PHENYL-1 -[2-(1 -PIPERIDINYL)PHE-NYL]ETHYL]AMINO]-2-OXOETHYL] BENZOIC ACID)
|
瑞格列奈杂质
|
107362-12-9
|
Rivastigmine
|
卡巴拉汀杂质
|
123441-03-2
|
Rosuvastatin IMpurity (5-Oxo Rosuvastatin tert-Butyl Ester)
|
瑞舒伐他汀杂质
|
|
|
奥美沙坦杂质
|
|
Pantoprazole IMpurity (Mixture of IMpurity D and F)
|
泮托拉唑杂质
|
|
SalbutaMol IMpurity C
|
沙丁胺醇杂质
|
|
SalMeterol IMpurity
|
沙美特罗杂质
|
|
Sertraline IMpurity (SRTRC-3)
|
舍曲林杂质
|
|
Sildenafil Aldehyde IMpurity
|
西地那非杂质
|
|
Sitagliptin iMpurity
|
西他列汀杂质
|
|
Stugeron
|
桂利嗪杂质
|
298-57-7
|
TaMsulosin EP IMpurity
|
坦索罗辛杂质
|
|
TICARCILLIN IMPURITY
|
替卡西林杂质
|
|
TOPOTECANACETATE
|
拓扑替康杂质
|
123948-88-9
|
TranexaMic Acid iMpurity
|
氨甲环酸杂质
|
|
Valaciclovir iMpurity
|
伐昔洛韦杂质
|
|
COLURACETAM
|
N-(2,3-二甲基-5,6,7,8-四氢呋喃并[2,3-B]喹啉-4-基)-2-(2-氧代吡咯烷-1-基)乙酰胺;考拉西坦
|
135463-81-9
|
(3S)-3-[4-[(2-Chloro-5-iodophenyl)methyl]phenoxy]tetrahydro-furan
|
(3S)-3-[4-[(2-氯-5-碘苯基)甲基]苯氧基]四氢呋喃(依帕列净中间体);依帕列净杂质 C;(S)-3-(4-(2-氯-5-碘苄基)-苯氧基)-四氢呋喃
|
915095-94-2
|
(E)-3α-hydroxy-6-ethylidene-7-keto-5β-cholan-24-oic acid
|
奥贝胆酸中间体-3;3A羟基-7氧代-胆烷酸甲酯;奥贝胆酸中间体;奥贝胆酸中间体 OB-3
|
1516887-33-4
|
2-(4-Fluorophenyl)-5-[(5-iodo-2-methylphenyl)methyl]thiophene
|
坎格列净中间体;坎格列净的中间体;2-(2-甲基-5-溴苄基)-5-(4-氟苯)噻吩(坎格列净中间体);卡格列净 中间体 KG-1.1
|
898566-17-1
|
2-(5-BroMo-2-Methylbenzyl)-5-(4-fluorophenyl)thiophene
|
2-(2-甲基-5-溴苄基)-5-(4-氟苯)噻吩;2-[(5-溴-2-甲基苯基)甲基]-5-(4-氟苯基)噻吩;坎格列净中间体1
|
1030825-20-7
|
Canagliflozin
|
卡格列净(半水合物)
|
928672-86-0
|
Canagliflozin
|
卡格列净(无水合物)
|
842133-18-0
|
Carfilzomib
|
卡非佐米
|
868540-17-4
|
EMpagliflozin
|
(1S)-1,5-脱水-1-C-[4-氯-3-[[4-[[(3S)-四氢-3-呋喃基]氧基]苯基]甲基]苯基]-D-葡萄糖醇;艾帕列净;依帕列净;恩格列嗪;恩格列嗪 EMPAGLIFLOZIN;恩格列净/依帕列净;恩格列净;艾帕列净/依帕列净杂质
|
864070-44-0
|
(2S)-2-Amino-4-methyl-1-((2R)-2-methyloxiranyl)-1-pentanone Trifluoroacetate
|
卡非佐米侧链中间体
|
247068-85-5
|
ABT-199
|
|
1257044-40-8
|
AP26113
|
|
1197958-12-5
|
CO-1686
|
|
1374640-70-6
|
CO-1686
|
CO-1686 中间体二
|
68621-88-5
|
CO-1686
|
CO-1686 中间体三
|
1021426-42-5
|
CO-1686
|
CO-1686 中间体一
|
1374507-23-9
|
Edoxaban
|
依度沙班
|
1229194-11-9
|
LY2835219
|
|
1231929-97-7
|
LY2835219
|
LY2835219 中间体一
|
1231930-42-9
|
LY2835219
|
LY2835219中间体二
|
1180132-17-5
|
LY2835219
|
LY2835219中间体三
|
1231930-37-2
|
LY2835219
|
LY2835219中间体四
|
1231930-33-8
|
Rucaparib
|
|
459868-92-9
|
Vortioxetine
|
沃替西汀
|
508233-74-7
|
Vortioxetine (Lu AA21004) HBr
|
沃替西汀氢溴酸盐
|
960203-27-4
|
WZ3146
|
|
1214265-56-1
|
WZ4002
|
|
1213269-23-8
|
WZ8040
|
|
1214265-57-2
|
|
盐酸纳曲酮杂质A
|
|
|
盐酸纳曲酮杂质B
|
|
|
盐酸纳曲酮杂质c
|
|
1,2,3-Trithiane-4-pentanoic Acid
|
硫辛酸杂质A
|
1204245-29-3
|
(S)-Cinacalcet hydrochloride
|
S-盐酸西那卡塞
|
1217809-88-5
|
|
S-邻氯苯甘氨酸甲酯酒石酸盐
|
141109-14-0
|
|
3-氯-4-氨基苯酚盐酸盐
|
52671-64-4
|
|
恩替卡韦杂质
|
|
|
2,3,4-三氟-5-硝基苯甲酸甲酯
|
918321-24-1
|
J
|
替米沙坦杂质J
|
|